Further, since inflammation of various levels has often been associated with tumor development, and ICAM-1 expression is up-regulated in lymphatic vessels during inflammation, interaction between MAC-1 and ICAM-1 expressed on DCs and inflamed lymphatic endothelium, respectively, may lead to decreased ability of DCs to activate T cells. The gene discussed is ITGB2; the disease is neoplasm.